Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
173 rows where in_cev_map = 0 and surface_class = "A2_pm_peripheral" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
surface_class 1
- A2_pm_peripheral · 173 ✖
in_cev_map 1
- - · 173 ✖
has_activation_state_pdb_pair 1
- 0 173
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P25054 | APC | Adenomatous polyposis coli protein | Tier 1 | 0.644 | 1 | A2_pm_peripheral | 31 | 0 | 0 | 1 | 39 | 41471356, 40788329, 40207978, 39796151, 39335496, 39189513, 38710049, 38509823, 37199793, 37185533, 36894782, 36882463, 36827736, 36252203, 35544380, 35490167, 34837173, 34708097, 34240523, 34008621, 32486960, 32429721, 32386347, 31937772, 31295701, 31249960, 30609568, 29886066, 29666278, 27736370, 27427891, 26552824, 26552816, 25059182, 24681393, 22236082, 19389630, 19029139, 9546673 | 0 | familial adenomatous polyposis 1 | 0.8462165290909345 | |||
| Q9Y4U1 | MMACHC | Cyanocobalamin reductase / alkylcobalamin dealkylase | Tier 1.5 | 0.644 | 1 | A2_pm_peripheral | 7 | 85.62 | 0 | 0 | 0 | 0 | 0 | Methylmalonic acidemia with homocystinuria, type cblC | 0.8478185420804271 | |||
| Q9Y215 | COLQ | Acetylcholinesterase collagenic tail peptide | Tier 1.5 | 0.629 | 1 | A2_pm_peripheral | 1 | 54.47 | 0 | 0 | 0 | 0 | 0 | Congenital myasthenic syndromes | 0.796199449860989 | |||
| Q4FZB7 | KMT5B | Histone-lysine N-methyltransferase KMT5B | Tier 1 | 0.628 | 1 | A2_pm_peripheral | 10 | 54.91 | 1 | 0 | 0 | 0 | 0 | intellectual disability, autosomal dominant 51 | 0.7943209483524042 | |||
| Q68CZ1 | RPGRIP1L | Protein fantom | Tier 1.5 | 0.628 | 1 | A2_pm_peripheral | 1 | 70.06 | 0 | 0 | 0 | 0 | 0 | Joubert syndrome with hepatic defect | 0.7930231953177929 | |||
| Q5JVL4 | EFHC1 | EF-hand domain-containing protein 1 | Tier 1 | 0.626 | 1 | A2_pm_peripheral | 2 | 83.88 | 1 | 0 | 0 | 0 | 0 | juvenile myoclonic epilepsy | 0.7858434985198706 | |||
| P49459 | UBE2A | Ubiquitin-conjugating enzyme E2 A | Tier 1.5 | 0.626 | 1 | A2_pm_peripheral | 5 | 94.12 | 1 | 0 | 0 | 0 | 0 | syndromic X-linked intellectual disability Nascimento type | 0.7867796040270276 | |||
| O75800 | ZMYND10 | Zinc finger MYND domain-containing protein 10 | Tier 1 | 0.625 | 1 | A2_pm_peripheral | 2 | 88.75 | 0 | 0 | 0 | 0 | 0 | primary ciliary dyskinesia | 0.7822239837882315 | |||
| Q86SQ9 | DHDDS | Dehydrodolichyl diphosphate synthase complex subunit DHDDS | Tier 1 | 0.624 | 1 | A2_pm_peripheral | 9 | 94.75 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa 59 | 0.7786578489187141 | |||
| O43586 | PSTPIP1 | Proline-serine-threonine phosphatase-interacting protein 1 | Tier 1 | 0.624 | 1 | A2_pm_peripheral | 4 | 85.75 | 0 | 0 | 0 | 0 | 0 | pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 0.7793785829807485 | |||
| Q8NFD5 | ARID1B | AT-rich interactive domain-containing protein 1B | Tier 1 | 0.624 | 1 | A2_pm_peripheral | 2 | 46.19 | 0 | 0 | 0 | 0 | 0 | Coffin-Siris syndrome 1 | 0.7813407475430133 | |||
| P15104 | GLUL | Glutamine synthetase | Tier 1.5 | 0.622 | 1 | A2_pm_peripheral | 12 | 97.5 | 1 | 0 | 1 | 4 | 39533430, 30085248, 21282981 | 0 | congenital brain dysgenesis due to glutamine synthetase deficiency | 0.7733687702812198 | ||
| Q9NPP4 | NLRC4 | NLR family CARD domain-containing protein 4 | Tier 1 | 0.619 | 1 | A2_pm_peripheral | 6 | 85.12 | 1 | 0 | 0 | 0 | 0 | periodic fever-infantile enterocolitis-autoinflammatory syndrome | 0.7635956406357429 | |||
| Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | Tier 1.5 | 0.619 | 1 | A2_pm_peripheral | 1 | 63.19 | 0 | 0 | 0 | 0 | 0 | Recurrent infection due to specific granule deficiency | 0.7619369036825959 | |||
| P10636 | MAPT | Microtubule-associated protein tau | Tier 1 | 0.618 | 1 | A2_pm_peripheral | 100 | 49.22 | 1 | 0 | 1 | 9 | 40380000, 39241336, 38585969, 38397086, 37003060, 31900535, 30004544, 29268187 | 0 | Pick disease | 0.7600399335134378 | ||
| Q96CW9 | NTNG2 | Netrin-G2 | Tier 1.5 | 0.616 | 1 | A2_pm_peripheral | 3 | 84.5 | 0 | 0 | 0 | 0 | 0 | neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia | 0.7527757254195254 | |||
| P35716 | SOX11 | Transcription factor SOX-11 | Tier 1 | 0.614 | 1 | A2_pm_peripheral | 4 | 56.41 | 1 | 0 | 0 | 0 | 0 | intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism | 0.7470288070793535 | |||
| P48788 | TNNI2 | Troponin I, fast skeletal muscle | Tier 1.5 | 0.613 | 1 | A2_pm_peripheral | 2 | 80.69 | 0 | 0 | 0 | 0 | 0 | distal arthrogryposis type 2B1 | 0.7424838485252128 | |||
| O15350 | TP73 | Tumor protein p73 | Tier 1 | 0.612 | 1 | A2_pm_peripheral | 28 | 65.19 | 0 | 0 | 0 | 0 | 0 | ciliary dyskinesia, primary, 47, and lissencephaly | 0.7409037542174439 | |||
| P12643 | BMP2 | Bone morphogenetic protein 2 | Tier 1 | 0.611 | 1 | A2_pm_peripheral | 21 | 79.56 | 0 | 0 | 1 | 10 | 41144653, 38542880, 37231465, 35591468, 35195734, 34067593, 33997500 | 0 | short stature, facial dysmorphism, and skeletal anomalies with or without cardiac anomalies 1 | 0.7361833785834584 | ||
| O14640 | DVL1 | Segment polarity protein dishevelled homolog DVL-1 | Tier 1.5 | 0.611 | 1 | A2_pm_peripheral | 3 | 59.84 | 0 | 0 | 1 | 1 | 37231925 | 0 | autosomal dominant Robinow syndrome | 0.7359277384599506 | ||
| Q6EMB2 | TTLL5 | Tubulin polyglutamylase TTLL5 | Tier 1.5 | 0.607 | 1 | A2_pm_peripheral | 1 | 61.41 | 0 | 0 | 0 | 0 | 0 | Cone rod dystrophy | 0.72210835127064 | |||
| P41159 | LEP | Leptin | Tier 1 | 0.606 | 1 | A2_pm_peripheral | 10 | 81.12 | 1 | 0 | 1 | 14 | 40330320, 40008515, 39263947, 37331044, 36508319, 36173490, 35884340, 34016094, 33650854, 32527800, 27530235, 26529285, 23232067, 20594164 | 0 | obesity due to congenital leptin deficiency | 0.7197450249224271 | ||
| Q8N136 | DAW1 | Dynein assembly factor with WD repeat domains 1 | Tier 1 | 0.596 | 1 | A2_pm_peripheral | 1 | 96.62 | 0 | 0 | 0 | 0 | 0 | ciliary dyskinesia, primary, 52 | 0.6876653910907874 | |||
| Q9BWF2 | TRAIP | E3 ubiquitin-protein ligase TRAIP | Tier 1.5 | 0.595 | 1 | A2_pm_peripheral | 1 | 74.94 | 0 | 0 | 0 | 0 | 0 | Seckel syndrome 9 | 0.683878095944948 | |||
| Q4KMQ1 | TPRN | Taperin | Tier 1.5 | 0.595 | 1 | A2_pm_peripheral | 1 | 54.44 | 0 | 0 | 0 | 0 | 0 | hearing loss, autosomal recessive | 0.6844134134291492 | |||
| Q9H6P5 | TASP1 | Threonine aspartase 1 | Tier 1 | 0.594 | 1 | A2_pm_peripheral | 10 | 86.81 | 0 | 0 | 0 | 0 | 0 | Suleiman-El-Hattab syndrome | 0.6801464403674466 | |||
| Q8IUC6 | TICAM1 | TIR domain-containing adapter molecule 1 | Tier 1.5 | 0.581 | 1 | A2_pm_peripheral | 8 | 62.78 | 1 | 0 | 0 | 0 | 0 | Herpetic encephalitis | 0.6364986386236531 | |||
| P50607 | TUB | Tubby protein homolog | Tier 1.5 | 0.579 | 1 | A2_pm_peripheral | 1 | 69.12 | 0 | 0 | 0 | 0 | 0 | retinitis pigmentosa | 0.631297844631827 | |||
| Q2Q1W2 | TRIM71 | E3 ubiquitin-protein ligase TRIM71 | Tier 1.5 | 0.578 | 1 | A2_pm_peripheral | 2 | 79.12 | 0 | 0 | 1 | 2 | 31732746 | 0 | hydrocephalus, congenital communicating, 1 | 0.6276048232841862 | ||
| Q9UQC2 | GAB2 | GRB2-associated-binding protein 2 | Tier 1 | 0.572 | 1 | A2_pm_peripheral | 10 | 51.91 | 0 | 0 | 0 | 0 | 0 | cancer | 0.6072358553557748 | |||
| Q8IWB6 | TEX14 | Inactive serine/threonine-protein kinase TEX14 | Tier 1 | 0.571 | 1 | A2_pm_peripheral | 2 | 50.47 | 0 | 0 | 0 | 0 | 0 | spermatogenic failure 23 | 0.603775324929283 | |||
| P56597 | NME5 | Nucleoside diphosphate kinase 5 | Tier 1.5 | 0.563 | 1 | A2_pm_peripheral | 1 | 90.06 | 1 | 0 | 0 | 0 | 0 | ciliary dyskinesia, primary, 48, without situs inversus | 0.5766985649142533 | |||
| Q13882 | PTK6 | Protein-tyrosine kinase 6 | Tier 1 | 0.56 | 1 | A2_pm_peripheral | 9 | 88.81 | 0 | 0 | 0 | 0 | 0 | medullary thyroid gland carcinoma | 0.5657289152364859 | |||
| P51813 | BMX | Cytoplasmic tyrosine-protein kinase BMX | Tier 1 | 0.555 | 1 | A2_pm_peripheral | 6 | 75.75 | 0 | 0 | 1 | 1 | 34962102 | 0 | alopecia areata | 0.5491699656070116 | ||
| O76083 | PDE9A | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | Tier 1 | 0.553 | 1 | A2_pm_peripheral | 25 | 81.0 | 0 | 0 | 0 | 0 | 0 | coronary artery disease | 0.5429744031742744 | |||
| Q96RU8 | TRIB1 | Tribbles homolog 1 | Tier 1 | 0.552 | 1 | A2_pm_peripheral | 5 | 76.56 | 0 | 0 | 1 | 1 | 36579647 | 0 | neurodegenerative disease | 0.5397808385585621 | ||
| Q9BVS4 | RIOK2 | Serine/threonine-protein kinase RIO2 | Tier 1 | 0.552 | 1 | A2_pm_peripheral | 10 | 67.38 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.539818754658029 | |||
| Q86T24 | ZBTB33 | Transcriptional regulator Kaiso | Tier 1 | 0.551 | 1 | A2_pm_peripheral | 19 | 54.78 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5355170277816887 | |||
| Q9NXF7 | DCAF16 | DDB1- and CUL4-associated factor 16 | Tier 1 | 0.548 | 1 | A2_pm_peripheral | 2 | 38.19 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5251061120759617 | |||
| Q8WWN9 | IPCEF1 | Interactor protein for cytohesin exchange factors 1 | Tier 1.5 | 0.547 | 1 | A2_pm_peripheral | 1 | 64.06 | 0 | 0 | 0 | 0 | 0 | response to tramadol | 0.5225136314922196 | |||
| Q14678 | KANK1 | KN motif and ankyrin repeat domain-containing protein 1 | Tier 1 | 0.546 | 1 | A2_pm_peripheral | 5 | 53.97 | 0 | 0 | 0 | 0 | 0 | basal cell carcinoma | 0.5204468359739138 | |||
| Q8N8R7 | ARL14EP | ARL14 effector protein | Tier 1.5 | 0.546 | 1 | A2_pm_peripheral | 1 | 80.69 | 0 | 0 | 0 | 0 | 0 | endometriosis | 0.5215169504121038 | |||
| Q5TC82 | RC3H1 | Roquin-1 | Tier 1 | 0.545 | 1 | A2_pm_peripheral | 6 | 61.12 | 0 | 0 | 1 | 2 | 27010430 | 0 | hemophagocytic lymphohistiocytosis, familial, 6 | 0.5161798637096334 | ||
| O43663 | PRC1 | Protein regulator of cytokinesis 1 | Tier 1 | 0.544 | 1 | A2_pm_peripheral | 6 | 78.94 | 1 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5139662839321523 | |||
| P49789 | FHIT | Bis(5'-adenosyl)-triphosphatase | Tier 1 | 0.542 | 1 | A2_pm_peripheral | 9 | 95.25 | 0 | 0 | 0 | 0 | 0 | Abnormality of the skeletal system | 0.505651828927915 | |||
| P48775 | TDO2 | Tryptophan 2,3-dioxygenase | Tier 1 | 0.541 | 1 | A2_pm_peripheral | 22 | 90.06 | 0 | 0 | 0 | 0 | 0 | Hypertryptophanemia | 0.5037265368575525 | |||
| Q5UIP0 | RIF1 | Telomere-associated protein RIF1 | Tier 1.5 | 0.541 | 1 | A2_pm_peripheral | 1 | 53.78 | 0 | 0 | 0 | 0 | 0 | neurodegenerative disease | 0.5038900373620092 | |||
| Q96AT9 | RPE | Ribulose-phosphate 3-epimerase | Tier 1 | 0.54 | 1 | A2_pm_peripheral | 4 | 96.56 | 0 | 0 | 1 | 19 | 37958909, 31080896, 26923800, 25270019, 23539459, 22913867, 22710369, 22281826, 21701525, 21546514, 21448811, 21137477, 20623466, 19197318, 18628724, 18441313, 17891009, 17369776, 16815269 | 0 | neurodegenerative disease | 0.4992627094132485 | ||
| P11712 | CYP2C9 | Cytochrome P450 2C9 | Tier 1 | 0.536 | 1 | A2_pm_peripheral | 15 | 92.94 | 0 | 0 | 0 | 0 | 0 | cholesterol embolism | 0.4868290635834234 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;